These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Non palpable lesions of the breast: the Mammotome-biopsy in the preoperative management of breast cancer]. Ceccarelli G; Casciola L; Battistini I; Stefanoni M; Spaziani A; Conti D; Di Zitti L; Valeri R; Bartoli A; Bellochi R; Rambotti M; Pisanelli MC G Chir; 2005 May; 26(5):187-93. PubMed ID: 16184700 [TBL] [Abstract][Full Text] [Related]
3. [Surgical treatment of breast lesions: preliminary results of the screening program of the Ariana area]. Chelli D; Dimassi K; Salem A; Driss M; Zaanouni E; Zouaoui B; Sfar E; Ben Aissa R; Chelli H; Chennoufi BM; Boussen H Tunis Med; 2009 Jul; 87(7):475-9. PubMed ID: 20063683 [TBL] [Abstract][Full Text] [Related]
4. [Papillary lesions of the breast: diagnostic imaging and contribution of percutaneous needle biopsy with 14G needle]. Bazzocchi M; Berra I; Francescutti GE; Del Frate C; Zuiani C; Puglisi F; Di Loreto C Radiol Med; 2001 Jun; 101(6):424-31. PubMed ID: 11479438 [TBL] [Abstract][Full Text] [Related]
5. Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia. Port ER; Park A; Borgen PI; Morris E; Montgomery LL Ann Surg Oncol; 2007 Mar; 14(3):1051-7. PubMed ID: 17206485 [TBL] [Abstract][Full Text] [Related]
6. Excisional breast biopsy: when, why and how? Bellantone R; Rossi S; Lombardi CP; Cinini C; Minelli S; Crucitti F Int Surg; 1995; 80(1):75-8. PubMed ID: 7657498 [TBL] [Abstract][Full Text] [Related]
7. [Stereotaxic excisional biopsy of non-palpable breast lesions by the ABBI(Advanced Breast Biopsy Instrumentation) technique. Advantages. Disadvantages. Indications. Apropos of 67 cases]. Atallah N; Karam R; Younane T; Aftimos G J Med Liban; 2000; 48(2):70-6. PubMed ID: 11028153 [TBL] [Abstract][Full Text] [Related]
8. Experience with fine-wire localization breast biopsies for nonpalpable breast lesions detected mammographically. Luoma AA; Scudamore CH; Longley JD Can J Surg; 1986 Sep; 29(5):315-8. PubMed ID: 3790211 [TBL] [Abstract][Full Text] [Related]
9. Benign breast lesions at risk of developing cancer--a challenging problem in breast cancer screening programs: five years' experience of the Breast Cancer Screening Program in Verona (1999-2004). Manfrin E; Mariotto R; Remo A; Reghellin D; Falsirollo F; Dalfior D; Bricolo P; Piazzola E; Bonetti F Cancer; 2009 Feb; 115(3):499-507. PubMed ID: 19117040 [TBL] [Abstract][Full Text] [Related]
10. The abnormal mammogram in women with clinically normal breasts. Sterns EE Can J Surg; 1995 Apr; 38(2):168-72. PubMed ID: 7728672 [TBL] [Abstract][Full Text] [Related]
11. [The "EVA" Trial: Evaluation of the Efficacy of Diagnostic Methods (Mammography, Ultrasound, MRI) in the secondary and tertiary prevention of familial breast cancer. Preliminary results after the first half of the study period]. Kuhl CK; Schrading S; Weigel S; Nüssle-Kügele K; Sittek H; Arand B; Morakkabati N; Leutner C; Tombach B; Nordhoff D; Perlet C; Rieber A; Heindel W; Brambs HJ; Schild H Rofo; 2005 Jun; 177(6):818-27. PubMed ID: 15902631 [TBL] [Abstract][Full Text] [Related]
12. [The use of stereotaxic cytology in the diagnosis of nonpalpable breast lesions. Our experience]. Cipolla C; Amato C; Grillo A; Graceffa G; Tomasino RM; Nuara RB; Morello V; Latteri MA Minerva Chir; 1999 Apr; 54(4):239-44. PubMed ID: 10380522 [TBL] [Abstract][Full Text] [Related]
13. [Surgical aspects of breast cancer screening at our hospital]. Márkus B; Bajner A; Csejtei A; Firisz B; Hegedus A; Kocsis E; Kovács B; Pintér G; Tóth C Magy Seb; 2006 Oct; 59(5):375-82. PubMed ID: 17201346 [TBL] [Abstract][Full Text] [Related]
14. Follow-up recommendations for benign breast biopsies. Shin S; Schneider HB; Cole FJ; Laronga C Breast J; 2006; 12(5):413-7. PubMed ID: 16958957 [TBL] [Abstract][Full Text] [Related]
15. A comparative analysis of core needle biopsy and fine-needle aspiration cytology in the evaluation of palpable and mammographically detected suspicious breast lesions. Garg S; Mohan H; Bal A; Attri AK; Kochhar S Diagn Cytopathol; 2007 Nov; 35(11):681-9. PubMed ID: 17924407 [TBL] [Abstract][Full Text] [Related]
16. Significant reduction in advanced breast cancer. Results of the first seven years of mammography screening in Kopparberg, Sweden. Tabár L; Gad A; Holmberg L; Ljungquist U Diagn Imaging Clin Med; 1985; 54(3-4):158-64. PubMed ID: 3896614 [TBL] [Abstract][Full Text] [Related]
17. [Early detection of breast cancer by mass screening using mammography]. Morimoto T; Sasa M; Yamaguchi T; Harada K; Kondo H; Kuroda R Gan To Kagaku Ryoho; 1994 Jun; 21 Suppl 2():158-63. PubMed ID: 8037479 [TBL] [Abstract][Full Text] [Related]
18. [Radiosurgical labeling of non-palpable mammary lesions]. Aguirre B; Gutiérrez L; Ortega D; Laupheimer S; Taborga M Rev Med Chil; 1997 Sep; 125(9):1032-5. PubMed ID: 9595794 [TBL] [Abstract][Full Text] [Related]
19. Breast fine needle aspiration cytology. Utility as a screening tool for clinically palpable lesions. Costa MJ; Tadros T; Hilton G; Birdsong G Acta Cytol; 1993; 37(4):461-71. PubMed ID: 8328240 [TBL] [Abstract][Full Text] [Related]
20. [Diagnostic role of mammography and clinical examination in the framework of a screening program for breast carcinoma in Brescia]. Filippini L; Pinelli D; Bettoni C; Bianchi A; Perna F; Lucini L; Vaiana R; Braga M Minerva Med; 1996 Nov; 87(11):531-8. PubMed ID: 9045104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]